Evidence map›Paper›PMID 38467675›Full record

ArticleScientific reports2024

Comprehensive study reveals phenotypic heterogeneity in Klebsiella pneumoniae species complex isolates.

Nadia Rodríguez-Medina, Jonathan Rodríguez-Santiago, Alejandro Alvarado-Delgado, Alan Sagal-Prado, Jesús Silva-Sánchez, Miguel A De la Cruz, Miguel Angel Ares, Margarita Sánchez-Arias, Rayo Morfín-Otero, Rigoberto Hernández-Castro and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Phenotypic and genome-based characterization ofFrontiers in microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Complete genome sequences ofMicrobiology resource announcements · 2025
    Article
  10. Article
  11. Molecular Epidemiology and In-Depth Characterization ofInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Nadia Rodríguez-Medina *Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Instituto Nacional de Salud Pública (INSP), Av. Universidad # 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
Jonathan Rodríguez-Santiago *Centro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Instituto Nacional de Salud Pública (INSP), Av. Universidad # 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
Alejandro Alvarado-DelgadoCentro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Instituto Nacional de Salud Pública (INSP), Av. Universidad # 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
Alan Sagal-PradoCentro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Instituto Nacional de Salud Pública (INSP), Av. Universidad # 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
Jesús Silva-SánchezCentro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Instituto Nacional de Salud Pública (INSP), Av. Universidad # 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
Miguel A De la CruzFacultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Miguel Angel AresUnidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Margarita Sánchez-AriasCentro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Instituto Nacional de Salud Pública (INSP), Av. Universidad # 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico.
Rayo Morfín-OteroHospital Civil de Guadalajara "Fray Antonio Alcalde", Instituto de Patología Infecciosa y Experimental, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
Rigoberto Hernández-CastroDepartamento de Agentes Patógenos, Hospital General "Dr. Manuel Gea González", Mexico City, Mexico.
Patricia Cornejo-JuárezInstituto Nacional de Cancerología, Mexico City, Mexico.
Emmanuel Jiménez-VillanuevaHospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
Domingo Sánchez-FranciaHospital del Niño y el Adolescente Morelense, Zapata, Morelos, Mexico.
Ulises Garza-RamosCentro de Investigación Sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Instituto Nacional de Salud Pública (INSP), Av. Universidad # 655, Col. Santa María Ahuacatitlán, C.P. 62100, Cuernavaca, Morelos, Mexico. ulises.garza@insp.mx.
Instituto Nacional de Salud Pública · MXBenemérita Universidad Autónoma de Puebla · MXHospital Civil de Guadalajara · MXHospitales Regionales de Alta Especialidad · MXHospital General Dr. Manuel Gea Gonzalez · MXInstituto Nacional de Cancerología · MXMexican Social Security Institute · MX

Funding

Consejo Nacional de Ciencia y Tecnología 347316
6 · The paper itself

Abstract

Here, we conducted a comprehensive analysis of 356 Klebsiella pneumoniae species complex (KpSC) isolates that were classified as classical (cl), presumptive hypervirulent (p-hv) and hypermucoviscous-like (hmv-like). Overall, K. pneumoniae (82.3%), K. variicola (2.5%) and K. quasipneumoniae (2.5%) were identified. These isolates comprised 321 cl-KpSC, 7 p-hv-KpSC and 18 hmv-like-KpSC. A large proportion of cl-KpSC isolates were extended-spectrum-β-lactamases (ESBLs)-producers (64.4%) and 3.4% of isolates were colistin-resistant carrying carbapenemase and ESBL genes. All p-hv-KpSC showed an antibiotic susceptible phenotype and hmv-like isolates were found to be ESBL-producers (8/18). Assays for capsule production and capsule-dependent virulence phenotypes and whole-genome sequencing (WGS) were performed in a subset of isolates. Capsule amount differed in all p-hv strains and hmv-like produced higher capsule amounts than cl strains; these variations had important implications in phagocytosis and virulence. Murine sepsis model showed that most cl strains were nonlethal and the hmv-like caused 100% mortality with 3 × 10

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeAnimalsAnti-Bacterial Agentsbeta-LactamasesColistinKlebsiellaMiceMicrobial Sensitivity TestsPhenotypePhylogenyAnti-Bacterial Agentsbeta-LactamasesColistinCapsuleColistin-resistanceHypermucoviscosityPlasmidsVirulence

Identifiers

PMID38467675
PMCPMC10928225
OpenAlexW4392649008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.